There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Medtronic (MDT) and Crispr Therapeutics …

In a report released today, Robert Drbul from Guggenheim maintained a Buy rating on Kohl’s (KSS), with a price target of $58.00.

In a report released today, Chad Messer from Needham reiterated a Buy rating on Athenex (ATNX), with a price target of $30.00.

Barrington analyst Gary Prestopino maintained a Hold rating on Copart (CPRT) today. The company’s shares closed last Monday at $86.

Analysts have been eager to weigh in on the Financial sector with new ratings on One Liberty Properties (OLP) and Ellington Financial (EFC). …

In a report released today, Ed Arce from H.C.

Evercore ISI analyst Joshua Schimmer upgraded Audentes Therapeutics (BOLD) to Buy today and set a price target of $40.00.

In a report released yesterday, Ed Arce from H.C.

In a report released yesterday, Chad Messer from Needham reiterated a Buy rating on Phasebio Pharmaceuticals (PHAS), with a price target of $20.00.

There’s a lot to be optimistic about in the Materials sector as 3 analysts just weighed in on Newmont Mining (NEM), Pan American …